CARL — CARLSMED, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1794546 ·
Last close
$17.74
Market Cap
$486.15M
52W High
$19.15
52W Low
$8.50
ADV30
124,932
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 21,554,000 | 16,665,000 | -12,701,000 | -12,245,000 | 115,270,000 | 35,945,000 | 39,596,000 |
| Jun 2026 | 18,940,000 | 14,542,000 | -11,036,000 | -10,510,000 | 118,202,000 | 46,244,000 | 33,956,000 |
| Mar 2026 | 16,116,000 | 12,425,000 | -9,276,000 | -8,696,000 | 118,769,000 | 73,016,000 | 26,521,000 |
| Dec 2025 | 15,165,000 | 11,608,000 | -9,318,000 | -8,613,000 | 130,120,000 | 85,793,000 | 31,251,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-34,360,000
Investing CF
$-45,890,000
Financing CF
$822,000
CapEx
$-1,788,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.48
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-132,294,000
Inventory
$2,987,000
Receivables
$16,884,000
ST Investments
$44,262,000
EBIT TTM
$-38,794,000
Pretax Income TTM
$-40,064,000
Interest Exp TTM
$1,270,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$71,775,000
EBITDA
$-41,878,000
Free Cash Flow
$-22,692,624
Enterprise Value
$410,736,000
Total Cash
$80,207,000
Total Debt
$21,785,000
Shares Out
27,404,088
Trailing EPS
$-1.13
Book Value
$2.76
ROE
-43.9%
ROA
-21.2%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 50,511,000 | -30,574,000 | -29,634,000 | 130,120,000 | 31,251,000 | 98,869,000 | -28,977,000 |
| Dec 2024 | 27,165,000 | -24,122,000 | -24,257,000 | 51,824,000 | 122,454,000 | -70,630,000 | -25,466,000 |
| Dec 2023 | 13,778,000 | -18,591,000 | -18,898,000 | 14,024,000 | 60,154,000 | -46,130,000 | -17,480,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$118,202,000
Forward EPS
$-1.56
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ANGO | ANGIODYNAMICS INC | $483.21M | $11.49 | — |
| RCEL | AVITA Medical, Inc. | $495.50M | $15.77 | — |
| MDXG | MIMEDX GROUP, INC. | $464.04M | $3.18 | — |
| AVR | Anteris Technologies Global Corp. | $518.67M | $5.32 | — |
| OBIO | Orchestra BioMed Holdings, Inc. | $548.57M | $6.97 | — |
News headlines (Yahoo Finance, 1h cache)
Carlsmed to Participate in Upcoming Investor Conferences
2026-11-16 21:01 · Yahoo
Carlsmed (CARL) Stock Sees Fair Value Lift After Analysts React To Q3 Strength
2026-11-16 07:07 · Yahoo
DeGen Medical Moves to Dismiss Carlsmed Patent Suit, Vows to Fight Remaining Claims
2026-11-15 22:50 · Yahoo
Carlsmed Inc (CARL) (Q3 2026) Earnings Call Highlights: Revenue Surges 65% as Guidance Raised ...
2026-11-11 05:08 · Yahoo
Carlsmed (CARL) Q3 2026 Earnings Call Transcript
2026-11-11 03:19 · Yahoo
Carlsmed Q3 Earnings Call Highlights
2026-11-11 00:14 · Yahoo
Carlsmed, Inc. (CARL) Reports Q3 Loss, Tops Revenue Estimates
2026-11-10 21:40 · Yahoo
Carlsmed® Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance
2026-11-10 21:01 · Yahoo
Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026
2026-10-27 20:30 · Yahoo
Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
2026-10-14 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.